EP 1102585 A2 20010530 - USE OF CYCLOPENTABENZOFURAN-DERIVATIVES FOR COMBATING NF-$g(k)B-DEPENDENT DISEASES
Title (en)
USE OF CYCLOPENTABENZOFURAN-DERIVATIVES FOR COMBATING NF-$g(k)B-DEPENDENT DISEASES
Title (de)
VERWENDUNG VON CYCLOPENTABENZOFURANDERIVATEN ZUR BEKAEMPFUNG VON NF-KB ABHANGIGEN KRANKHEITEN
Title (fr)
UTILISATION DE DERIVES DE CYCLOPENTABENZOFURANNE POUR LUTTER CONTRE DES MALADIES DEPENDANT DU NF-$g(k)B
Publication
Application
Priority
- DE 19835325 A 19980805
- EP 9905426 W 19990729
Abstract (en)
[origin: DE19835325A1] The invention relates to the use of cyclopentabenzofuran derivatives for the preparation of a medicament for the treatment of nuclear factor kappa B-dependent diseases.
IPC 1-7
IPC 8 full level
A61K 31/343 (2006.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); A61P 11/06 (2006.01)
CPC (source: EP US)
A61K 31/343 (2013.01 - EP US); A61P 7/02 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/06 (2017.12 - EP)
Citation (search report)
See references of WO 0007579A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
DE 19835325 A1 20000210; AU 5729099 A 20000228; EP 1102585 A2 20010530; US 6518274 B1 20030211; WO 0007579 A2 20000217; WO 0007579 A3 20000908
DOCDB simple family (application)
DE 19835325 A 19980805; AU 5729099 A 19990729; EP 9905426 W 19990729; EP 99944303 A 19990729; US 76244801 A 20010418